Evaluating the clinical effect and safety of gatifloxacin in the treatment of community acquired pneumonia / 中国基层医药

0.05).Conclusion Gatifloxation is safe and efficient in the treatment of community acquired pneomonia.

Analysis of the cost-effect in curing community-acquired pneumonia with levufloxacin and gatifioxacin / 中国基层医药

0.05).Conclusion Levofloxacin treating community-acquired pneumonia than gatifloxacin have more medicine economics advantage and it is in the prior choice.